key: cord-0767678-4jbo82nr
authors: Xiao, Ai Tang; Tong, Yi Xin; Gao, Chun; Zhu, Li; Zhang, Yu Jie; Zhang, Sheng
title: Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study
date: 2020-04-11
journal: J Clin Virol
DOI: 10.1016/j.jcv.2020.104346
sha: bbda64bc03cf420c886826a11264b1e1c5311875
doc_id: 767678
cord_uid: 4jbo82nr

BACKGROUND: With the spread of Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection, its effect on society is amplified. We aimed to describe the viral detection results across different timepoints throughout the disease course. METHODS: A retrospective study of 301 confirmed COVID-19 patients hospitalized at Tongji Hospital in Wuhan, China, were included. Demographic characteristics of the patients were collected. Upper respiratory specimens (throat and/or nasal swabs) were obtained and analyzed by real-time RT-PCR for SARS-CoV-2 infection. Period of viral infection and the contagious stage were analyzed. RESULTS: Of 301 hospitalized COVID-19 patients, the median age was 58 years and 51.2% were male. The median period between symptoms presence and positive SARS-CoV-2 RT-PCR results was 16 days (IQR, 10-23, N = 301). The median period between symptoms presence and an effective negative SARS-CoV-2 RT-PCR result was 20 days (IQR, 17-24; N = 216). Infected patient ≥65 years old stayed contagious longer (22 days vs 19 days, p = 0.015). Although two consecutive negative results were confirmed in 70 patients, 30% of them had positive viral test results for the third time. Using specimens from nasal swabs to run the RT-PCR test showed a higher positive rate than using specimens from throat swabs. CONCLUSIONS: This large-scale investigation with 1113 RT-PCR test results from 301 COVID-19 patients showed that the average contagious period of SARS-CoV-2 infected patients was 20 days. Longer observation period and more than 2 series of negative viral test are necessary for patients ≥65 years.

To date, an outbreak of infectious diseases--coronavirus disease 2019 (COVID- 19) associated with Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) continues in Wuhan, Hubei Province, China. [1] [2] The clinical manifestations of patients with COVID-19 included fever, dyspnea, fatigue, dry cough, myalgia, lymphopenia and radiographic findings of pneumonia. For severe and critical cases, patients suffered from acute respiratory distress syndrome (ARDS), acute respiratory failure, other serious complications and even death. 3-4 The spread of virus has struck Wuhan, and even the whole country, and has caused unmeasurable losses in every aspect. Over 50 countries are fighting against the disease. As of Feb 26 th ,2020, 81,015 cases were diagnosed worldwide, and 2762 patients died from this disease (death rate 3.41%). 1 

Genomic studies have shown that SARS-CoV-2 shared around 80% identity sequencing with SARS-CoV, which caused a global epidemic with 8096 confirmed cases worldwide in 2002-2003. 5 Presumed person-to-person transmission of SARS-CoV-2 was suggested based on epidemiology and clinical evidences. 6-8 Recent reports suggested that asymptomatic COVID-19 infected individuals could also be the source of transmission. 9-10 To successfully contained the epidemic of SARS-CoV-2, public health interventions such as disease detection and isolation were critical.

Currently, the dynamic profile of SARS-CoV-2 viral load after onset of symptoms is not clear. Recent report by Zou et al from 18 patients with COVID-19 suggested that the viral nucleic acid shedding pattern of SARS-CoV-2 appears different from that in patients with SARS-CoV. 9 Therefore, the aim of this large-scale retrospective study was to analyze the dynamic profile of SARS-CoV-2 and to explore the impact of demographic parameters on it. Prevention. [11] [12] All data (test dates and results of RT-PCR assay) were collected up to the final follow-up date (February 26 th , 2020).

Data (clinical information and results of RT-PCR for SARS-CoV-2 viral nucleic acid detection) were collected from the electronic medical record system. The following information were collected for analysis: 1. Demographic characteristics such as age and gender; 2. Clinical characteristics such as date of onset (defined as the first date when the symptoms were reported), date of admission and date of discharge; 3. SARS-CoV-2 RT-PCR characteristics. Throat and/or nasal swabs were collected for the SARS-CoV-2 viral nucleic acid detection in sequential time-points. Positive SARS-CoV-2 RT-PCR assay is defined as the period from the date of onset to the date of last positive RT-PCR test result. Effective negative SARS-CoV-2 RT-PCR assay is defined as the period from the date of onset to the date of first negative RT-PCR test result (In some cases, patients got positive RT-PCR results following false negative results, which were considered non-effective negative results in our study).

Throat swab samples or deep nasal cavity swab samples were collected for extracting 

All continuous variables were presented as medians (interquartile range, IQR) and analyzed with Mann-Whitney U test. Categorical variables were reported as whole J o u r n a l P r e -p r o o f numbers and percentages. All p values were reported as two-sided with a significance level of 0.05. All statistical tests were performed in SPSS version 24.0 (IBM, NY, USA).

A total of 301 patients diagnosed as COVID-19 were included in this study. According to the guideline, 12 all included patients were mild to moderate. No patient was transferred to ICU. The median age was 58 years (IQR, 44-68; range, 10-92 years), comprising 154 (51.2%) men and 147 (48.8%) women. The median period from symptom onset to admission was 9 days (IQR, 7-12; range, 0-31). On the last follow-up day (February 26 th , 2020), 246 (81.7%) patients were still hospitalized while 55 (18.3%) patients were discharged. ( Table 1) 

The total number of SARS-CoV-2 RT-PCR assay from 301 included COVID-19 patients was 1113, with 3.7 tests per patient. The median period from symptoms onset to the first RT-PCR assay was 8 days (IQR, 5-12; range, 0-32). (Table 1 

We investigated the impact of age and gender on the dynamic profile of SARS-CoV-2 by RT-PCR assay. As shown in Figure 2A , However, the difference is not statistically significant.

Of the 301 patients, 70 (23.3%) had the records of three consecutive SARS-CoV-2 RT-PCR assays with the negative results for the first two tests. Among these 70 patients, 21 (30%) patients had positive SARS-CoV-2 RT-PCR results for the third time. As illustrated in Figure 3A , older (≥65 years) patients had a higher third-time positive rate (32%, 7/22) than younger(29%, 14/48) patients had, although the difference is not significant (p=0.82). 

This is a large-scale report from 301 COVID-19 patients with 1113 samples of RT-PCR tests for SARS-CoV-2 detection. The data and results from this study is notable for providing solid evidence of SARS-CoV-2 dynamic profile in patients infected. Smoking and alcohol history may relate to the above finding.

As a result of errors in sampling and testing, false negative result of RT-PCR for SARS-CoV-2 is very common in clinical settings. Meanwhile, it is recommended by the current diagnosis and treatment guideline for SARS-CoV-2 from Chinese National Health Committee that the criteria to discharge a patient included the relief of symptoms, improvement in radiography and two consecutive negative RT-PCR results for SARS-CoV-2. 12 We analyzed results from 70 patients with three consecutive viral tests. We found that 21 patients (30%) had a positive third-time RT-PCR test, even though the results were negative for the previous two tests. (Figure 3A ) This evidence revealed the defect (high false positive rate) of current SARS-CoV-2 detection method and questioned the criteria for discharge and discontinuation of quarantine mentioned above. Releasing potential contagions to public will have substantial influence in disease control and transmission, especially when patients were asymptomatic. 10, [16] [17] Recent report of 18 COVID-19 patients by Zou et al suggested that higher viral loads were detected in the nose than in the throat. 9 We compared the results of SARS-CoV-2 RT-PCR assay for 37 pairs of specimens from nasal and throat swabs. Positive nasal swabs and negative throat swabs were found in 12 pairs (32.4%) of samples, compared to only 2 pairs of samples were positive throat swabs and negative nasal swabs. (Figure 3B) . 46 pairs of samples are an initial negative SARS-CoV-2 RT-PCR assay from throat swabs followed by a sequential SARS-CoV-2 RT-PCR assay from J o u r n a l P r e -p r o o f nasal swabs. We found that 19 pairs (41.3%) of samples from nasal swabs were positive regardless of the initial negative throat swabs. These findings suggested that upper respiratory specimens obtained from nasal swabs were more sensitive and reliable for SARS-CoV-2 RT-PCR assay.

To the date of this manuscript drafted (February 27 th , 2020), COVID-19 rapidly spreads from Wuhan to the entire country. The epidemic of COVID-19 also threatened countries such as Korea, Italy, Iraq and Japan, etc. 2 We have acquired some knowledge of the virus from series case reports and laboratory findings, while much work remains to be done and many questions remain unanswered. Evidence suggested that the outbreaks of COVID-19 may be correlated to its rapid person-to-person transmission ability. Since specific treatment had not been validated for COVID-19, traditional public health tactics-isolation, quarantine and community containment are critical to control the spread. [17] [18] [19] [20] This study has found valuable and solid evidence of the dynamic profile of SARS-CoV-2 and offered suggestion to improve current detection method and criteria for discharge. The overall period of patient infected by SARS-CoV-2 was relatively long especially in old individuals. Therefore, we suggested prolonged observation and repeat confirmation of RT-PCR assay from nasal swabs specimens for safe discharges.

The present study has several limitations that should be taken into consideration.

First, in this retrospective setting, the accuracy of SARS-CoV-2 RT-PCR may vary (improvement of the detection protocol and gain of experience in sampling). Second, this study only investigated the impact of age and gender on dynamic profile of SARS-J o u r n a l P r e -p r o o f CoV-2, while other factors were not included. Third, some information of such as RT-PCR test after discharge, period of negative SARS-CoV-2 RT-PCR test result in some included patients were incomplete. Therefore, a prospective study with a strict inclusion criteria and more clinical-pathological measurements are needed to validate the findings.

In summary, in this study we for the first time provided information of SARS-CoV-2 dynamic profile, with the median duration for viral conversion of 20 days after onset of symptom. Old age is the risk factor for prolonged virus replication (22 days). Throat swabs should be replaced by nasal swabs to obtain the specimens for viral detection and the current criteria for discharge should be adjusted.

All authors declare that there are no conflicts of interest.

Ethical approval This study was approved by the Ethics committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. All procedures followed in this study were in accordance with the 1964 Helsinki Declaration and later versions.

Informed consent Oral consent was obtained from patients involved before enrollment when data were collected retrospectively.

The database used and/or analyzed during the current study is not publicly available (to maintain privacy) but can be available from the corresponding author on reasonable request. 

Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

China National Health Commission. Diagnosis and treatment of 2019-nCoV pneumonia in China. (Version 5) In Chinese

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis

Importation and human-to-human transmission of a novel coronavirus in Vietnam

Early transmission dynamics inWuhan, China, of novel coronavirus-infected pneumonia

SARS to novel coronavirus: old lessons and new lessons

Risk for transportation of 2019 novel coronavirus disease from Wuhan to other cities in China

Positive RT-PCR test results in patients Positive SARS-CoV-2 RT-PCR assay Negative SARS-CoV-2 RT-PCR assay 16

Abbreviations: IQR, interquartile range; RT-PCR, real-time reverse transcription polymerase chain reaction

The authors declare that they have no competing interests. No financial support to declare. We thank Ms. Cheng Chen for English grammatic correction of this manuscript.

All authors participated in the study design. ATX and SZ conceived the study, analyzed the data and drafted the manuscript. CG, YXT helped critically revise the manuscript for important intellectual content. YJZ and ZL helped collect data and design the study.All authors have agreed on the final version and meet the major criteria recommended by the ICMJE (http://www.icmje.org/)Funding No funding resources to declare for this study.